Endometriosis is a chronic, incurable condition that affects about 10% of women of reproductive age. It is defined as a growth of cells similar to the womb lining outside of the womb in the pelvis, and is associated with chronic pelvic pain, excessive period pain, pain with sexual intercourse and difficulties in getting pregnant. If the disease is found only on the lining of the pelvis it is known as "superficial peritoneal" and is usually treated during a laparoscopic surgery by cutting out (excision) or burning off (ablation). However, many women do not find improvement in their symptoms after the surgery and can have complications from the procedure. The aim of this study is to determine if removal of the superficial peritoneal endometriosis improves pain symptoms and quality of life, which method of removal (excision or ablation) is more effective or if surgical removal is of no benefit to the patients and can potentially cause harm. The investigators plan to recruit up to 90 women from four NHS hospitals in Scotland over a period of 12 months. Women who are attending gynaecology departments with pelvic pain who have not previously had a diagnosis of endometriosis via laparoscopy will be approached. Patients will be asked to read an information sheet about the trial. Women who consent to the trial will be randomised during the surgery, if superficial endometriosis is found, to either having the endometriosis removed or not. For this pilot, follow up will be at 3 and 6 months (and obtain permission to continue to follow them up at 12 and 24 months should time and finding permit). Patients who do not consent to take part in the trial will be asked if the investigators can collect data on their demographics and reasons on why they did not wish to take part.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
7
In the active comparator group patients will have endometriosis lesions removed by ablation or excision. Patients randomised to no surgical treatment arm will not have lesions removed and will only be given diagnosis on whether endometriosis was found or not.
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom
Proportion of women with suspected SPE undergoing diagnostic laparoscopy that were approached for the study an agreed to randomisation
The proportion of screened women who are eligible for the trial determined from the screening logs
Time frame: Screening
Baseline characteristics of eligible women that agree to be randomised and those that decline participation
Baseline characteristics including age, social deprivation, ethnicity and duration of pain collected from screened women
Time frame: Screening
Proportion of women having laparoscopy for investigation of chronic pelvic pain that are eligible (i.e. have only SPE) for the trial
The proportion of women undergoing diagnostic laparoscopy who go on to be diagnosed with SPE
Time frame: visit 2 (day of surgery)
Effects of treatment and variability in treatment outcomes
Intraoperative and postoperative complications
Time frame: visit 2 (day of surgery), 30 days post surgery
Improvement in quality of life
Endometriosis Health Profile-30 (EHP-30)
Time frame: 30 days post surgery, follow up at 3 and 6 months
Improvement in quality of life
Rome IV criteria
Time frame: day of surgery, follow up at 3 and 6 months
Improvement in quality of life
Pelvic Pain and Urgency/Frequency Patient (PUF) Symptom Scale
Time frame: day of surgery, follow up at 3 and 6 months
Improvement in quality of life
PainDetect TM
Time frame: day of surgery, follow up at 3 and 6 months
Improvement in quality of life
Brief Fatigue Inventory (BFI)
Time frame: day of surgery, follow up at 3 and 6 months
Improvement in quality of life
Pain Catastrophising Questionnaire (PCQ)
Time frame: day of surgery, follow up at 3 and 6 months
Improvement in quality of life
Fibromyalgia Scale
Time frame: day of surgery, follow up at 3 and 6 months
Improvement in quality of life
Measure Yourself Medical Outcome Profile 2 (MYMOP 2)
Time frame: day of surgery, follow up at 3 and 6 months
Improvement in quality of life
Working Productivity and Activity Impairment Questionnaire (WPAIQ)
Time frame: day of surgery, follow up at 3 and 6 months
Improvement in quality of life
EuroQol 5 Dimensions 5 Level Questionnaire (EQ-5D-5L)
Time frame: day of surgery, follow up at 3 and 6 months
Effects of treatment and variability in treatment outcomes
Number of patients who needed analgesia after laparoscopy recorded during follow up.
Time frame: 30 days post surgery, follow up at 3 and 6 months
Effects of treatment and variability in treatment outcomes
Number of patients who needed medical management with ovarian suppression after laparoscopy recorded during follow up.
Time frame: 30 days post surgery, follow up at 3 and 6 months
Effects of treatment and variability in treatment outcomes
Adverse events (as reported by the participants)
Time frame: Throughout the trial starting from day of surgery until end of followup at 6 months
To determine the most acceptable methods of recruitment and assessment tools
The proportion of completed trial questionnaires
Time frame: Questionnaires collected at Baseline (within a week of surgery), 3 and 6 months follow up
To determine the most acceptable methods of assessment tools
Number of patients who remained blinded for 6 months after the surgery recorded by asking patient if they were told their allocation
Time frame: Throughout the trial until end of follow up at 6 months
To determine the most acceptable methods of recruitment, randomisation and assessment tools
Acceptability of the trial completed at 6 months after surgery will be compared between two arms.
Time frame: 6 months follow up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.